8-K: HealthEquity Reports Strong Fiscal Year and Q4 2025 Results, Revenue Jumps 20%

HealthEquity announces a 20% increase in revenue for fiscal year 2025, reaching $1.20 billion, alongside significant growth in net income and adjusted EBITDA.

Summary

• HealthEquity reported its fiscal year and fourth quarter results, ending January 31, 2025.
• The company's fiscal year revenue increased by 20% to $1.20 billion, compared to $999.6 million in the previous year.
• Net income for the fiscal year rose by 74% to $96.7 million, or $1.09 per diluted share.
• Non-GAAP net income increased by 42% to $277.3 million, or $3.12 per diluted share.
• Adjusted EBITDA for the fiscal year was $471.8 million, a 28% increase.
• The company's HSA count reached 9.9 million, a 14% increase year-over-year.
• Total HSA assets grew by 27% to $32.1 billion.
• For the fourth quarter, revenue increased by 19% to $311.8 million.
• Net income for the fourth quarter remained the same as the prior year at $26.4 million, or $0.30 per diluted share.
• Adjusted EBITDA for the fourth quarter increased by 9% to $107.8 million.
• HealthEquity completed the acquisition of the BenefitWallet HSA portfolio during the year.
• The company repurchased 1.4 million shares of its common stock for $122.2 million.
• For fiscal year 2026, HealthEquity anticipates revenues between $1.280 billion and $1.305 billion.
• The company expects net income between $164 million and $179 million, or $1.85 to $2.01 per diluted share, and adjusted EBITDA between $525 million and $545 million.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results and growth metrics, indicating a favorable sentiment.

Positives

• Significant revenue growth of 20% for the fiscal year.
• Substantial increase in net income, up 74% for the fiscal year.
• Strong growth in adjusted EBITDA, increasing by 28% for the fiscal year.
• Increase in HSA accounts by 14% year-over-year.
• Growth in total HSA assets by 27% year-over-year.
• Successful acquisition of the BenefitWallet HSA portfolio.
• Active stock repurchase program, returning capital to shareholders.

Negatives

• Fourth quarter net income remained flat compared to the previous year.
• Adjusted EBITDA margin decreased in Q4 2025 to 35% compared to 38% in Q4 2024.

Risks

• The company faces risks related to safeguarding custodial assets.
• Competition in the healthcare and benefits administration industry is intense.
• The company is dependent on the tax-advantaged status of HSAs and CDBs.
• Cybersecurity breaches and data interruptions could harm the company's reputation and financial results.
• Changes in healthcare programs and regulations could impact the business.
• The company relies on partners and third-party vendors for distribution and important services.

Future Outlook

For fiscal year 2026, HealthEquity expects revenues of $1.280 billion to $1.305 billion, net income between $164 million and $179 million, and adjusted EBITDA between $525 million and $545 million.

Management Comments

• Team Purple finished fiscal 25 in strong fashion, with record revenues and major strides in advancing our strategic initiatives, allowing us to provide our outlook for an even stronger fiscal 26, said Scott Cutler, President and Chief Executive Officer of HealthEquity.
• With a focus on Member First Secure Mobile Experiences, we are executing against our 3Ds strategy to Deepen partnerships, Deliver remarkable experiences, and Drive member outcomes for our Clients, Network Partners, and members.

Industry Context

HealthEquity's strong performance reflects the growing adoption of HSAs as a vehicle for healthcare savings and investment. The company's focus on technology and member experience positions it well in a competitive market.

Comparison to Industry Standards

• HealthEquity's growth in HSA accounts and assets under management is competitive with other HSA custodians like Optum Bank and Fidelity.
• The acquisition of BenefitWallet is similar to other consolidation activities in the HSA market, such as HSA Bank's acquisition of Further.
• HealthEquity's adjusted EBITDA margin of 39% for the fiscal year is within the range of other financial technology companies.

Stakeholder Impact

• Shareholders benefit from the company's strong financial performance and stock repurchase program.
• Employees benefit from the company's growth and success.
• Customers benefit from the company's focus on member experience and technology.
• The company's growth supports its partners and vendors.

Next Steps

• HealthEquity management will host a conference call on March 18, 2025, to discuss the results.
• The company will continue to execute its 3Ds strategy to deepen partnerships, deliver remarkable experiences, and drive member outcomes.

Key Dates